메뉴 건너뛰기




Volumn 9, Issue , 2011, Pages

Histone modification enhances the effectiveness of IL-13 receptor targeted immunotoxin in murine models of human pancreatic cancer

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; ANTINEOPLASTIC AGENT; BISULFITE; BUTYRIC ACID; DNA; HISTONE; HISTONE DEACETYLASE INHIBITOR; INTERLEUKIN 13 RECEPTOR ALPHA2; MATRIX METALLOPROTEINASE; MESSENGER RNA; PSEUDOMONAS EXOTOXIN; SR 11302; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; TRANSCRIPTION FACTOR AP 1; TRICHOSTATIN A; UNCLASSIFIED DRUG; VORINOSTAT; COMPLEMENTARY DNA; IMMUNOTOXIN; INTERLEUKIN 13; INTERLEUKIN 13 RECEPTOR;

EID: 79953742165     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-9-37     Document Type: Article
Times cited : (24)

References (34)
  • 1
    • 33646263592 scopus 로고    scopus 로고
    • Characterization of a novel human tumor antigen interleukin-13 receptor alpha2 chain
    • 10.1158/0008-5472.CAN-05-1265, 16618770
    • Kawakami K, Terabe M, Kawakami M, Berzofsky JA, Puri RK. Characterization of a novel human tumor antigen interleukin-13 receptor alpha2 chain. Cancer Res 2006, 66:4434-4442. 10.1158/0008-5472.CAN-05-1265, 16618770.
    • (2006) Cancer Res , vol.66 , pp. 4434-4442
    • Kawakami, K.1    Terabe, M.2    Kawakami, M.3    Berzofsky, J.A.4    Puri, R.K.5
  • 2
    • 0036813331 scopus 로고    scopus 로고
    • Cancer/testis antigens: an expanding family of targets for cancer immunotherapy
    • 10.1034/j.1600-065X.2002.18803.x, 12445278
    • Scanlan MJ, Gure AO, Jungbluth AA, Old LJ, Chen YT. Cancer/testis antigens: an expanding family of targets for cancer immunotherapy. Immunol Rev 2002, 188:22-32. 10.1034/j.1600-065X.2002.18803.x, 12445278.
    • (2002) Immunol Rev , vol.188 , pp. 22-32
    • Scanlan, M.J.1    Gure, A.O.2    Jungbluth, A.A.3    Old, L.J.4    Chen, Y.T.5
  • 3
    • 0035871986 scopus 로고    scopus 로고
    • Interleukin-13 receptor as a unique target for anti-glioblastoma therapy
    • 10.1002/1097-0215(200102)9999:9999<::AID-IJC1182>3.0.CO;2-N, 11291041
    • Husain SR, Joshi BH, Puri RK. Interleukin-13 receptor as a unique target for anti-glioblastoma therapy. Int J Cancer 2001, 92:168-175. 10.1002/1097-0215(200102)9999:9999<::AID-IJC1182>3.0.CO;2-N, 11291041.
    • (2001) Int J Cancer , vol.92 , pp. 168-175
    • Husain, S.R.1    Joshi, B.H.2    Puri, R.K.3
  • 4
    • 0029934957 scopus 로고    scopus 로고
    • Targeting of interleukin-13 receptor on human renal cell carcinoma cells by a recombinant chimeric protein composed of interleukin-13 and a truncated form of Pseudomonas exotoxin A (PE38QQR)
    • Puri RK, Leland P, Obiri NI, Husain SR, Kreitman RJ, Haas GP, Pastan I, Debinski W. Targeting of interleukin-13 receptor on human renal cell carcinoma cells by a recombinant chimeric protein composed of interleukin-13 and a truncated form of Pseudomonas exotoxin A (PE38QQR). Blood 1996, 87:4333-4339.
    • (1996) Blood , vol.87 , pp. 4333-4339
    • Puri, R.K.1    Leland, P.2    Obiri, N.I.3    Husain, S.R.4    Kreitman, R.J.5    Haas, G.P.6    Pastan, I.7    Debinski, W.8
  • 5
    • 0036705806 scopus 로고    scopus 로고
    • Improved anti-tumor activity and safety of interleukin-13 receptor targeted cytotoxin by systemic continuous administration in head and neck cancer xenograft model
    • 2040009, 12435859
    • Kawakami K, Husain SR, Kawakami M, Puri RK. Improved anti-tumor activity and safety of interleukin-13 receptor targeted cytotoxin by systemic continuous administration in head and neck cancer xenograft model. Mol Med 2002, 8:487-494. 2040009, 12435859.
    • (2002) Mol Med , vol.8 , pp. 487-494
    • Kawakami, K.1    Husain, S.R.2    Kawakami, M.3    Puri, R.K.4
  • 6
    • 0031029303 scopus 로고    scopus 로고
    • Receptor for interleukin 13 on AIDS-associated Kaposi's sarcoma cells serves as a new target for a potent Pseudomonas exotoxin-based chimeric toxin protein
    • Husain SR, Obiri NI, Gill P, Zheng T, Pastan I, Debinski W, Puri RK. Receptor for interleukin 13 on AIDS-associated Kaposi's sarcoma cells serves as a new target for a potent Pseudomonas exotoxin-based chimeric toxin protein. Clin Cancer Res 1997, 3:151-156.
    • (1997) Clin Cancer Res , vol.3 , pp. 151-156
    • Husain, S.R.1    Obiri, N.I.2    Gill, P.3    Zheng, T.4    Pastan, I.5    Debinski, W.6    Puri, R.K.7
  • 7
    • 33749005099 scopus 로고    scopus 로고
    • Interleukin-13 receptor alpha2 chain: a potential biomarker and molecular target for ovarian cancer therapy
    • 10.1002/cncr.22134, 16902988
    • Kioi M, Kawakami M, Shimamura T, Husain SR, Puri RK. Interleukin-13 receptor alpha2 chain: a potential biomarker and molecular target for ovarian cancer therapy. Cancer 2006, 107:1407-1418. 10.1002/cncr.22134, 16902988.
    • (2006) Cancer , vol.107 , pp. 1407-1418
    • Kioi, M.1    Kawakami, M.2    Shimamura, T.3    Husain, S.R.4    Puri, R.K.5
  • 8
    • 0028859363 scopus 로고
    • Human glioma cells overexpress receptors for interleukin 13 and are extremely sensitive to a novel chimeric protein composed of interleukin 13 and pseudomonas exotoxin
    • Debinski W, Obiri NI, Powers SK, Pastan I, Puri RK. Human glioma cells overexpress receptors for interleukin 13 and are extremely sensitive to a novel chimeric protein composed of interleukin 13 and pseudomonas exotoxin. Clin Cancer Res 1995, 1:1253-1258.
    • (1995) Clin Cancer Res , vol.1 , pp. 1253-1258
    • Debinski, W.1    Obiri, N.I.2    Powers, S.K.3    Pastan, I.4    Puri, R.K.5
  • 9
    • 0029041783 scopus 로고
    • A novel chimeric protein composed of interleukin 13 and Pseudomonas exotoxin is highly cytotoxic to human carcinoma cells expressing receptors for interleukin 13 and interleukin 4
    • 10.1074/jbc.270.28.16775, 7622490
    • Debinski W, Obiri NI, Pastan I, Puri RK. A novel chimeric protein composed of interleukin 13 and Pseudomonas exotoxin is highly cytotoxic to human carcinoma cells expressing receptors for interleukin 13 and interleukin 4. J Biol Chem 1995, 270:16775-16780. 10.1074/jbc.270.28.16775, 7622490.
    • (1995) J Biol Chem , vol.270 , pp. 16775-16780
    • Debinski, W.1    Obiri, N.I.2    Pastan, I.3    Puri, R.K.4
  • 10
    • 0036284481 scopus 로고    scopus 로고
    • Heterogeneity in interleukin-13 receptor expression and subunit structure in squamous cell carcinoma of head and neck: differential sensitivity to chimeric fusion proteins comprised of interleukin-13 and a mutated form of Pseudomonas exotoxin
    • Joshi BH, Kawakami K, Leland P, Puri RK. Heterogeneity in interleukin-13 receptor expression and subunit structure in squamous cell carcinoma of head and neck: differential sensitivity to chimeric fusion proteins comprised of interleukin-13 and a mutated form of Pseudomonas exotoxin. Clin Cancer Res 2002, 8:1948-1956.
    • (2002) Clin Cancer Res , vol.8 , pp. 1948-1956
    • Joshi, B.H.1    Kawakami, K.2    Leland, P.3    Puri, R.K.4
  • 11
    • 11844306593 scopus 로고    scopus 로고
    • Optimization of expression and purification of two biologically active chimeric fusion proteins that consist of human interleukin-13 and Pseudomonas exotoxin in Escherichia coli
    • 10.1016/j.pep.2004.10.012, 15642470
    • Joshi BH, Puri RK. Optimization of expression and purification of two biologically active chimeric fusion proteins that consist of human interleukin-13 and Pseudomonas exotoxin in Escherichia coli. Protein Expr Purif 2005, 39:189-198. 10.1016/j.pep.2004.10.012, 15642470.
    • (2005) Protein Expr Purif , vol.39 , pp. 189-198
    • Joshi, B.H.1    Puri, R.K.2
  • 12
    • 16544381261 scopus 로고    scopus 로고
    • Distribution kinetics of targeted cytotoxin in glioma by bolus or convection-enhanced delivery in a murine model
    • 10.3171/jns.2004.101.6.1004, 15597761
    • Kawakami K, Kawakami M, Kioi M, Husain SR, Puri RK. Distribution kinetics of targeted cytotoxin in glioma by bolus or convection-enhanced delivery in a murine model. J Neurosurg 2004, 101:1004-1011. 10.3171/jns.2004.101.6.1004, 15597761.
    • (2004) J Neurosurg , vol.101 , pp. 1004-1011
    • Kawakami, K.1    Kawakami, M.2    Kioi, M.3    Husain, S.R.4    Puri, R.K.5
  • 13
    • 33947723884 scopus 로고    scopus 로고
    • Role of interleukin-13 in cancer, pulmonary fibrosis, and other T(H)2-type diseases
    • Joshi BH, Hogaboam C, Dover P, Husain SR, Puri RK. Role of interleukin-13 in cancer, pulmonary fibrosis, and other T(H)2-type diseases. Vitam Horm 2006, 74:479-504.
    • (2006) Vitam Horm , vol.74 , pp. 479-504
    • Joshi, B.H.1    Hogaboam, C.2    Dover, P.3    Husain, S.R.4    Puri, R.K.5
  • 14
    • 33947547455 scopus 로고    scopus 로고
    • Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study Group
    • 10.1200/JCO.2006.08.1117, 17327604
    • Kunwar S, Prados MD, Chang SM, Berger MS, Lang FF, Piepmeier JM, Sampson JH, Ram Z, Gutin PH, Gibbons RD, et al. Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study Group. J Clin Oncol 2007, 25:837-844. 10.1200/JCO.2006.08.1117, 17327604.
    • (2007) J Clin Oncol , vol.25 , pp. 837-844
    • Kunwar, S.1    Prados, M.D.2    Chang, S.M.3    Berger, M.S.4    Lang, F.F.5    Piepmeier, J.M.6    Sampson, J.H.7    Ram, Z.8    Gutin, P.H.9    Gibbons, R.D.10
  • 15
    • 74549138477 scopus 로고    scopus 로고
    • Interleukin 13 mediates signal transduction through interleukin 13 receptor alpha2 in pancreatic ductal adenocarcinoma: role of IL-13 Pseudomonas exotoxin in pancreatic cancer therapy
    • Shimamura T, Fujisawa T, Husain SR, Joshi B, Puri RK. Interleukin 13 mediates signal transduction through interleukin 13 receptor alpha2 in pancreatic ductal adenocarcinoma: role of IL-13 Pseudomonas exotoxin in pancreatic cancer therapy. Clin Cancer Res 2009, 16:577-586.
    • (2009) Clin Cancer Res , vol.16 , pp. 577-586
    • Shimamura, T.1    Fujisawa, T.2    Husain, S.R.3    Joshi, B.4    Puri, R.K.5
  • 16
    • 79956020311 scopus 로고    scopus 로고
    • Targeting IL-13Ralpha2 in human pancreatic ductal adenocarcinoma with combination therapy of IL-13-PE and gemcitabine
    • Fujisawa T, Nakashima H, Nakajima A, Joshi BH, Puri RK. Targeting IL-13Ralpha2 in human pancreatic ductal adenocarcinoma with combination therapy of IL-13-PE and gemcitabine. Int J Cancer 2010,
    • (2010) Int J Cancer
    • Fujisawa, T.1    Nakashima, H.2    Nakajima, A.3    Joshi, B.H.4    Puri, R.K.5
  • 17
    • 50549096499 scopus 로고    scopus 로고
    • Interleukin-13 displaying retargeted oncolytic measles virus strains have significant activity against gliomas with improved specificity
    • 10.1038/mt.2008.152, 2748750, 18665158
    • Allen C, Paraskevakou G, Iankov I, Giannini C, Schroeder M, Sarkaria J, Puri RK, Russell SJ, Galanis E. Interleukin-13 displaying retargeted oncolytic measles virus strains have significant activity against gliomas with improved specificity. Mol Ther 2008, 16:1556-1564. 10.1038/mt.2008.152, 2748750, 18665158.
    • (2008) Mol Ther , vol.16 , pp. 1556-1564
    • Allen, C.1    Paraskevakou, G.2    Iankov, I.3    Giannini, C.4    Schroeder, M.5    Sarkaria, J.6    Puri, R.K.7    Russell, S.J.8    Galanis, E.9
  • 18
    • 10844296758 scopus 로고    scopus 로고
    • Specific recognition and killing of glioblastoma multiforme by interleukin 13-zetakine redirected cytolytic T cells
    • 10.1158/0008-5472.CAN-04-0454, 15604287
    • Kahlon KS, Brown C, Cooper LJ, Raubitschek A, Forman SJ, Jensen MC. Specific recognition and killing of glioblastoma multiforme by interleukin 13-zetakine redirected cytolytic T cells. Cancer Res 2004, 64:9160-9166. 10.1158/0008-5472.CAN-04-0454, 15604287.
    • (2004) Cancer Res , vol.64 , pp. 9160-9166
    • Kahlon, K.S.1    Brown, C.2    Cooper, L.J.3    Raubitschek, A.4    Forman, S.J.5    Jensen, M.C.6
  • 19
    • 2642531973 scopus 로고    scopus 로고
    • Epigenetics in human disease and prospects for epigenetic therapy
    • 10.1038/nature02625, 15164071
    • Egger G, Liang G, Aparicio A, Jones PA. Epigenetics in human disease and prospects for epigenetic therapy. Nature 2004, 429:457-463. 10.1038/nature02625, 15164071.
    • (2004) Nature , vol.429 , pp. 457-463
    • Egger, G.1    Liang, G.2    Aparicio, A.3    Jones, P.A.4
  • 20
    • 70449725209 scopus 로고    scopus 로고
    • Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies
    • 10.1016/S1474-4422(09)70262-5, 19833297
    • Urdinguio RG, Sanchez-Mut JV, Esteller M. Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies. Lancet Neurol 2009, 8:1056-1072. 10.1016/S1474-4422(09)70262-5, 19833297.
    • (2009) Lancet Neurol , vol.8 , pp. 1056-1072
    • Urdinguio, R.G.1    Sanchez-Mut, J.V.2    Esteller, M.3
  • 21
    • 68349135058 scopus 로고    scopus 로고
    • Histone modification patterns and epigenetic codes
    • Lennartsson A, Ekwall K. Histone modification patterns and epigenetic codes. Biochim Biophys Acta 2009, 1790:863-868.
    • (2009) Biochim Biophys Acta , vol.1790 , pp. 863-868
    • Lennartsson, A.1    Ekwall, K.2
  • 22
    • 34249337761 scopus 로고    scopus 로고
    • Perceptions of epigenetics
    • 10.1038/nature05913, 17522671
    • Bird A. Perceptions of epigenetics. Nature 2007, 447:396-398. 10.1038/nature05913, 17522671.
    • (2007) Nature , vol.447 , pp. 396-398
    • Bird, A.1
  • 23
    • 0036211013 scopus 로고    scopus 로고
    • Histone acetylation: a switch between repressive and permissive chromatin. Second in review series on chromatin dynamics
    • 10.1093/embo-reports/kvf053, 1084017, 11882541
    • Eberharter A, Becker PB. Histone acetylation: a switch between repressive and permissive chromatin. Second in review series on chromatin dynamics. EMBO Rep 2002, 3:224-229. 10.1093/embo-reports/kvf053, 1084017, 11882541.
    • (2002) EMBO Rep , vol.3 , pp. 224-229
    • Eberharter, A.1    Becker, P.B.2
  • 24
    • 20444479514 scopus 로고    scopus 로고
    • Drug insight: Histone deacetylase inhibitors--development of the new targeted anticancer agent suberoylanilide hydroxamic acid
    • Kelly WK, Marks PA. Drug insight: Histone deacetylase inhibitors--development of the new targeted anticancer agent suberoylanilide hydroxamic acid. Nat Clin Pract Oncol 2005, 2:150-157.
    • (2005) Nat Clin Pract Oncol , vol.2 , pp. 150-157
    • Kelly, W.K.1    Marks, P.A.2
  • 25
    • 20544471104 scopus 로고    scopus 로고
    • Histone deacetylase inhibitors in programmed cell death and cancer therapy
    • 10.4161/cc.4.4.1564, 15738652
    • Marks PA, Jiang X. Histone deacetylase inhibitors in programmed cell death and cancer therapy. Cell Cycle 2005, 4:549-551. 10.4161/cc.4.4.1564, 15738652.
    • (2005) Cell Cycle , vol.4 , pp. 549-551
    • Marks, P.A.1    Jiang, X.2
  • 26
    • 33845996135 scopus 로고    scopus 로고
    • Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)
    • 10.1182/blood-2006-06-025999, 1785068, 16960145
    • Duvic M, Talpur R, Ni X, Zhang C, Hazarika P, Kelly C, Chiao JH, Reilly JF, Ricker JL, Richon VM, Frankel SR. Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL). Blood 2007, 109:31-39. 10.1182/blood-2006-06-025999, 1785068, 16960145.
    • (2007) Blood , vol.109 , pp. 31-39
    • Duvic, M.1    Talpur, R.2    Ni, X.3    Zhang, C.4    Hazarika, P.5    Kelly, C.6    Chiao, J.H.7    Reilly, J.F.8    Ricker, J.L.9    Richon, V.M.10    Frankel, S.R.11
  • 27
    • 0034467913 scopus 로고    scopus 로고
    • Preclinical studies with IL-13PE38QQR for therapy of malignant glioma
    • 10.1358/dnp.2000.13.10.858450, 12879131
    • Joshi BH, Husain SR, Puri RK. Preclinical studies with IL-13PE38QQR for therapy of malignant glioma. Drug News Perspect 2000, 13:599-605. 10.1358/dnp.2000.13.10.858450, 12879131.
    • (2000) Drug News Perspect , vol.13 , pp. 599-605
    • Joshi, B.H.1    Husain, S.R.2    Puri, R.K.3
  • 28
    • 72249115096 scopus 로고    scopus 로고
    • A novel role of interleukin-13 receptor alpha2 in pancreatic cancer invasion and metastasis
    • 10.1158/0008-5472.CAN-09-2100, 19887609
    • Fujisawa T, Joshi B, Nakajima A, Puri RK. A novel role of interleukin-13 receptor alpha2 in pancreatic cancer invasion and metastasis. Cancer Res 2009, 69:8678-8685. 10.1158/0008-5472.CAN-09-2100, 19887609.
    • (2009) Cancer Res , vol.69 , pp. 8678-8685
    • Fujisawa, T.1    Joshi, B.2    Nakajima, A.3    Puri, R.K.4
  • 29
    • 56449096183 scopus 로고    scopus 로고
    • Human adrenomedullin up-regulates interleukin-13 receptor alpha2 chain in prostate cancer in vitro and in vivo: a novel approach to sensitize prostate cancer to anticancer therapy
    • 10.1158/0008-5472.CAN-08-2810, 19010904
    • Joshi BH, Leland P, Calvo A, Green JE, Puri RK. Human adrenomedullin up-regulates interleukin-13 receptor alpha2 chain in prostate cancer in vitro and in vivo: a novel approach to sensitize prostate cancer to anticancer therapy. Cancer Res 2008, 68:9311-9317. 10.1158/0008-5472.CAN-08-2810, 19010904.
    • (2008) Cancer Res , vol.68 , pp. 9311-9317
    • Joshi, B.H.1    Leland, P.2    Calvo, A.3    Green, J.E.4    Puri, R.K.5
  • 30
    • 0034162718 scopus 로고    scopus 로고
    • Interleukin-13 receptor alpha chain: a novel tumor-associated transmembrane protein in primary explants of human malignant gliomas
    • Joshi BH, Plautz GE, Puri RK. Interleukin-13 receptor alpha chain: a novel tumor-associated transmembrane protein in primary explants of human malignant gliomas. Cancer Res 2000, 60:1168-1172.
    • (2000) Cancer Res , vol.60 , pp. 1168-1172
    • Joshi, B.H.1    Plautz, G.E.2    Puri, R.K.3
  • 31
    • 0038262659 scopus 로고    scopus 로고
    • Potent antitumor activity of IL-13 cytotoxin in human pancreatic tumors engineered to express IL-13 receptor alpha2 chain in vivo
    • 10.1038/sj.gt.3301956, 12808442
    • Kawakami K, Kawakami M, Husain SR, Puri RK. Potent antitumor activity of IL-13 cytotoxin in human pancreatic tumors engineered to express IL-13 receptor alpha2 chain in vivo. Gene Ther 2003, 10:1116-1128. 10.1038/sj.gt.3301956, 12808442.
    • (2003) Gene Ther , vol.10 , pp. 1116-1128
    • Kawakami, K.1    Kawakami, M.2    Husain, S.R.3    Puri, R.K.4
  • 32
    • 0038421814 scopus 로고    scopus 로고
    • Molecular cloning and identification of the human interleukin 13 alpha 2 receptor (IL-13Ra2) promoter
    • 10.1215/S1152851702000510, 1920687, 12816724
    • Wu AH, Low WC. Molecular cloning and identification of the human interleukin 13 alpha 2 receptor (IL-13Ra2) promoter. Neuro Oncol 2003, 5:179-187. 10.1215/S1152851702000510, 1920687, 12816724.
    • (2003) Neuro Oncol , vol.5 , pp. 179-187
    • Wu, A.H.1    Low, W.C.2
  • 34
    • 72249084921 scopus 로고    scopus 로고
    • Enhanced antitumor activity induced by adoptive T-cell transfer and adjunctive use of the histone deacetylase inhibitor LAQ824
    • 10.1158/0008-5472.CAN-09-1456, 2779578, 19861533
    • Vo DD, Prins RM, Begley JL, Donahue TR, Morris LF, Bruhn KW, de la Rocha P, Yang MY, Mok S, Garban HJ, et al. Enhanced antitumor activity induced by adoptive T-cell transfer and adjunctive use of the histone deacetylase inhibitor LAQ824. Cancer Res 2009, 69:8693-8699. 10.1158/0008-5472.CAN-09-1456, 2779578, 19861533.
    • (2009) Cancer Res , vol.69 , pp. 8693-8699
    • Vo, D.D.1    Prins, R.M.2    Begley, J.L.3    Donahue, T.R.4    Morris, L.F.5    Bruhn, K.W.6    de la Rocha, P.7    Yang, M.Y.8    Mok, S.9    Garban, H.J.10


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.